Analysts Are Downgrading These 5 Pharmaceutical Stocks
In this article, we present the 5 pharmaceutical stocks that are being downgraded by analysts.
Repare Therapeutics Inc. (RPTX)
Market is closed
Sector: Investment Advice
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Biotechnology Value Fund / BVF Inc Mark Lampert | 5,858,776 | $83,429 | +21% | 3.33% |
| 2. | OrbiMed Advisors Samuel Isaly | 3,322,488 | $47,312 | 0.76% | |
| 3. | ARK Investment Management Catherine D. Wood | 2,875,315 | $40,944 | -4% | 0.17% |
| 4. | Redmile Group Jeremy Green | 2,732,996 | $38,918 | -3% | 1.21% |
| 5. | Deep Track Capital David Kroin | 2,664,017 | $37,936 | +27% | 2.43% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $12.73 | 6,168 | Large Shareholder | 412,604 | 2022-06-13 | Filing | |
| $12.73 | 68,327 | Large Shareholder | 3,299,906 | 2022-06-13 | Filing | |
| $12.73 | 74,666 | Large Shareholder | 4,443,423 | 2022-06-13 | Filing | |
| $13.21 | 20 | Large Shareholder | 406,436 | 2022-06-06 | Filing | |
| $12.29 | 31,903 | Large Shareholder | 406,416 | 2022-06-03 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $12.25 | 33,395 | Large Shareholder | 111,484 | 2022-06-03 | Filing | |
| $12.25 | 14,611 | Large Shareholder | 48,776 | 2022-06-03 | Filing | |
| $12.25 | 13,199 | Large Shareholder | 44,065 | 2022-06-03 | Filing | |
| $12.25 | 438,795 | Large Shareholder | 1,464,875 | 2022-06-03 | Filing | |
| $12.25 | 250,000 | Large Shareholder | 2,344,451 | 2022-06-03 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 145,990 | $2,078,897 | 0% | |
| 2. | 2,939,823 | $41,863 | 0% | |
| 3. | 2,581,097 | $36,755 | 15.62% | |
| 4. | 2,242,636 | $31,935 | 10.91% | |
| 5. | 2,088,345 | $29,738 | 0% |
News See All
10 Pharma Stocks to Buy According to Mark Lampert’s Biotechnology Value Fund
In this article, we examined Mark Lampert’s investment philosophy and decades of experience in the biotechnology space.
Were Hedge Funds Right About Repare Therapeutics Inc. (RPTX)?
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million holdings threshold to file a report that shows their positions at the end of every quarter.
Hedge Fund and Insider Trading News: Paul Marshall, Larry Robbins, Alden Global Capital, Square Inc (SQ), Repare Therapeutics Inc (RPTX), and More
Tribune Publishing’s largest shareholder, Alden Global Capital, said on Thursday it had offered to take full control of the owner of the Chicago Tribune in a deal that values the company at $520.6 million...
Hedge Fund and Insider Trading News: Coatue Management, Lone Pine Capital, Apollo Global Management, Heptagon Capital, SEB Investment Management, Zoom Video Communications Inc (ZM), Repare Therapeutics Inc (RPTX), and More
Pine Labs has raised $75-$100 million led by US-based billionaire Stephen Mandel's hedge fund Lone Pine Capital, valuing the Noida-based merchant-commerce startup at more than $2 billion.
Is RPTX A Good Stock To Buy Now?
At Insider Monkey, we pore over the filings of nearly 817 top investment firms every quarter, a process we have now completed for the latest reporting period.
Billionaire Hedge Funds
